Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018

World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*

by Matej Mikulic, last edited Jan 7, 2019
Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018 This statistic represents the worlds's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018. In that year, Tanvex Biopharma from Taiwan had the highest R&D intensity of over 800,000 percent. The R&D intensity is calculated from a company's R&D spending divided by the company's sales.
Show more

World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*

Loading statistic...
Expand statistic
R&D intensity
Tanvex Biopharma 821,643.6%
Obseva 342,928.1%
Verona Pharma 103,118.1%
Nantkwest 88,322.1%
Endocyte 82,756.3%
Regulus Therapeutics 70,840.3%
TG Therapeutics67,287.9%
Bellicum Pharma 35,393.7%
Intra-Cellular 32,305.2%
Revance Therapeutics 30,672.3%
Selecta Biosciences 20,269.7%
Dynavax Technologies 19,774%
Alder Biopharmaceuticals 15,514.7%
Flexion Therapeutics 14,431.3%
Clearside Biomedical 14,118.3%
Vtv Therapeutics 13,522%
Coherus Biosciences 10,336.2%
Northwest Biotherapeutics 9,874.7%
Ultragenyx Pharmaceutical 8,749.8%
Isotechnika Pharma 8,078.1%
Karyopharm Therapeutics 6,583.7%
Ascendis Pharma 6,463.3%
Idera Pharmaceuticals 5,515.6%
Stemline Therapeutics 5,493.5%
Cara Therapeutics 5,246.2%
Tigenix 5,031.6%
Syros Pharmaceuticals 3,705.3%
Otonomy 3,454.8%
Arcus Biosciences 3,241.7%
Mesoblast 2,877.5%
Unity Biotechnology 2,704.3%
Immunomedics 2,384.6%
Aclaris Therapeutics 2,364.2%
Syndax Pharma 2,286.6%
Dermira 2,199.3%
Wave Life Sciences 2,141.2%
Adverum Biotechnologies 2,054.6%
Proqr Therapeutics 1,720.2%
Spero Therapeutics 1,660.9%
Ocular 1,605.8%
Foamix Pharmaceuticals 1,574.8%
Ab Science 1,537.3%
Dicerna Pharmaceuticals 1,382.6%
Gw Pharmaceuticals 1,343.8%
Theravance Biopharma 1,130.2%
Chimerix 1,100.3%
Epizyme 996.6%
Spark Therapeutics 952.8%
Tetraphase Pharmaceuticals 952.2%
Rigel Pharmaceuticals 931.9%
R&D intensity
Tanvex Biopharma 821,643.6%
Obseva 342,928.1%
Verona Pharma 103,118.1%
Nantkwest 88,322.1%
Endocyte 82,756.3%
Regulus Therapeutics 70,840.3%
TG Therapeutics67,287.9%
Bellicum Pharma 35,393.7%
Intra-Cellular 32,305.2%
Revance Therapeutics 30,672.3%
Selecta Biosciences 20,269.7%
Dynavax Technologies 19,774%
Alder Biopharmaceuticals 15,514.7%
Flexion Therapeutics 14,431.3%
Clearside Biomedical 14,118.3%
Vtv Therapeutics 13,522%
Coherus Biosciences 10,336.2%
Northwest Biotherapeutics 9,874.7%
Ultragenyx Pharmaceutical 8,749.8%
Isotechnika Pharma 8,078.1%
Karyopharm Therapeutics 6,583.7%
Ascendis Pharma 6,463.3%
Idera Pharmaceuticals 5,515.6%
Stemline Therapeutics 5,493.5%
Cara Therapeutics 5,246.2%
Tigenix 5,031.6%
Syros Pharmaceuticals 3,705.3%
Otonomy 3,454.8%
Arcus Biosciences 3,241.7%
Mesoblast 2,877.5%
Unity Biotechnology 2,704.3%
Immunomedics 2,384.6%
Aclaris Therapeutics 2,364.2%
Syndax Pharma 2,286.6%
Dermira 2,199.3%
Wave Life Sciences 2,141.2%
Adverum Biotechnologies 2,054.6%
Proqr Therapeutics 1,720.2%
Spero Therapeutics 1,660.9%
Ocular 1,605.8%
Foamix Pharmaceuticals 1,574.8%
Ab Science 1,537.3%
Dicerna Pharmaceuticals 1,382.6%
Gw Pharmaceuticals 1,343.8%
Theravance Biopharma 1,130.2%
Chimerix 1,100.3%
Epizyme 996.6%
Spark Therapeutics 952.8%
Tetraphase Pharmaceuticals 952.2%
Rigel Pharmaceuticals 931.9%
Download Settings Share
Download started
Please be patient - this may take a moment
by Matej Mikulic, last edited Jan 7, 2019
This statistic represents the worlds's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018. In that year, Tanvex Biopharma from Taiwan had the highest R&D intensity of over 800,000 percent. The R&D intensity is calculated from a company's R&D spending divided by the company's sales.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Biotech industry
Biotech industry

All Information
in one Presentation

Biotech industry

Everything On "Biotech industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Biotech industry"
  • Global overview
  • U.S. companies
  • Research & development
The most important statistics
  • Products
  • Funding/investment
  • Biotech in agriculture
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.